Total Funding
38
10
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
426226
Tissue Genesis is an innovator of advanced tissue engineering and cell therapy solutions.
Anton C. Krucky: Co-founder, President and CEOPast Role: IBM, Executive in Global Product Development
Thomas F. Cannon: Co-Founder, Executive VP
About the Company
Tissue Genesis is an innovator of advanced tissue engineering and cell therapy solutions.
Tissue Genesis, founded in 2001, is rooted in bio-engineering with a combined twenty plus years of cell culture modeling, including the development of advanced cell biology flight hardware for NASA, NIH, and DOD on the Space Shuttle and ISS. Concurrently,
Tissue Genesis has focused on the more earthly medical needs of peripheral vascular disease and the use of a patient’s own cells to engineer superior grafts.
